Literature DB >> 14971895

Structure-activity studies of orexin a and orexin B at the human orexin 1 and orexin 2 receptors led to orexin 2 receptor selective and orexin 1 receptor preferring ligands.

Manja Lang1, Richard M Söll, Franz Dürrenberger, Frank M Dautzenberg, Annette G Beck-Sickinger.   

Abstract

The neuropeptides orexin A and B (also known as hypocretins) play an important role in many physiological and behavioral activities. Orexins are ligands of two closely related G-protein-coupled receptors, that are the named orexin 1 and orexin 2 receptors. To clearly identify the minimal ligand sequences required for receptor activation, we synthesized and analyzed different centrally, C- and N-terminally truncated analogues of orexins A and B. Furthermore, we used the shortest active analogue to screen for important amino acid residues by l-alanine and l-proline replacement scans. For orexin A, only full-length peptides were able to show the same activity as orexin A, but interestingly, reduced orexin A and natural orexin A, which contains the two disulfide bonds, had the same activity. The shortest highly active orexin B analogue was orexin B 6-28. In addition, we identified orexin A 2-33 as the first analogue with orexin 1 receptor preference and orexin B 10-28, [A27]orexin B 6-28, and [P11]orexin B 6-28 as being highly potent orexin 2 receptor selective (>1000-fold) peptides.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14971895     DOI: 10.1021/jm030982t

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

Review 1.  Understanding Peptide Binding in Class A G Protein-Coupled Receptors.

Authors:  Irina G Tikhonova; Veronique Gigoux; Daniel Fourmy
Journal:  Mol Pharmacol       Date:  2019-07-10       Impact factor: 4.436

Review 2.  Orexin/hypocretin based pharmacotherapies for the treatment of addiction: DORA or SORA?

Authors:  Shaun Yon-Seng Khoo; Robyn Mary Brown
Journal:  CNS Drugs       Date:  2014-08       Impact factor: 5.749

3.  Unique interaction pattern for a functionally biased ghrelin receptor agonist.

Authors:  Bjørn Sivertsen; Manja Lang; Thomas M Frimurer; Nicholas D Holliday; Anders Bach; Sylvia Els; Maja S Engelstoft; Pia S Petersen; Andreas N Madsen; Thue W Schwartz; Annette G Beck-Sickinger; Birgitte Holst
Journal:  J Biol Chem       Date:  2011-03-14       Impact factor: 5.157

4.  Crucial role of the orexin-B C-terminus in the induction of OX1 receptor-mediated apoptosis: analysis by alanine scanning, molecular modelling and site-directed mutagenesis.

Authors:  Pascal Nicole; Pierre Couvineau; Nadege Jamin; Thierry Voisin; Alain Couvineau
Journal:  Br J Pharmacol       Date:  2015-09-30       Impact factor: 8.739

5.  Truncated Orexin Peptides: Structure-Activity Relationship Studies.

Authors:  Nadezhda A German; Ann M Decker; Brian P Gilmour; Brian F Thomas; Yanan Zhang
Journal:  ACS Med Chem Lett       Date:  2013-12-12       Impact factor: 4.345

Review 6.  A Review of Single-Nucleotide Polymorphisms in Orexigenic Neuropeptides Targeting G Protein-Coupled Receptors.

Authors:  Mark D Ericson; Carrie Haskell-Luevano
Journal:  ACS Chem Neurosci       Date:  2018-05-11       Impact factor: 4.418

7.  Modeling of the OX1R-orexin-A complex suggests two alternative binding modes.

Authors:  Lasse Karhu; Ainoleena Turku; Henri Xhaard
Journal:  BMC Struct Biol       Date:  2015-05-09

8.  HPLC analysis of CSF hypocretin-1 in type 1 and 2 narcolepsy.

Authors:  Noriaki Sakai; Mari Matsumura; Ling Lin; Emmanuel Mignot; Seiji Nishino
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

Review 9.  Regulation of zebrafish sleep and arousal states: current and prospective approaches.

Authors:  Cindy N Chiu; David A Prober
Journal:  Front Neural Circuits       Date:  2013-04-09       Impact factor: 3.492

10.  Overlapping Distribution of Orexin and Endocannabinoid Receptors and Their Functional Interaction in the Brain of Adult Zebrafish.

Authors:  Roberta Imperatore; Livia D'Angelo; Omid Safari; Hamidreza Ahmadniaye Motlagh; Fabiana Piscitelli; Paolo de Girolamo; Luigia Cristino; Ettore Varricchio; Vincenzo di Marzo; Marina Paolucci
Journal:  Front Neuroanat       Date:  2018-07-30       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.